Montpellier, France

Georges Gaudriault

This inventor holds 4 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Medincell, Medincell S.a., Centre National De La Recherche Scientifique. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Georges Gaudriault. Retrieved from https://idiyas.com/inventor/georges-gaudriault-oddqeinm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 75.0

 

 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Georges Gaudriault

Introduction

Georges Gaudriault is a notable inventor based in Montpellier, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in drug delivery systems. With a total of three patents to his name, Gaudriault's work focuses on innovative methods for targeting and delivering pharmaceutical compounds effectively.

Latest Patents

One of Gaudriault's latest patents is a method for morselizing and/or targeting pharmaceutically active principles to synovial tissue. This method describes biodegradable drug delivery compositions that utilize a triblock copolymer containing a polyester and polyethylene glycol, along with a diblock copolymer. The composition is designed to deliver at least one pharmaceutically active principle effectively to synovial tissue. Another significant patent involves retro-inverso analogs of spadin, which display increased antidepressant effects. This patent outlines compositions and methods for treating depression using these analogs, as well as methods for blocking TREK-1 channel activity.

Career Highlights

Throughout his career, Georges Gaudriault has worked with prominent organizations such as Medincell and the Centre National de la Recherche Scientifique. His work in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Gaudriault has collaborated with esteemed colleagues, including Catherine Louise Heurteaux and Jean Mazella. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical technologies.

Conclusion

Georges Gaudriault's innovative work in drug delivery systems and his contributions to pharmaceutical sciences highlight his importance as an inventor. His patents reflect a commitment to advancing medical treatments and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…